Cargando…
SAMHD1 enhances nucleoside-analogue efficacy against HIV-1 in myeloid cells
SAMHD1 is an intracellular enzyme that specifically degrades deoxynucleoside triphosphates into component nucleoside and inorganic triphosphate. In myeloid-derived dendritic cells and macrophages as well as resting T-cells, SAMHD1 blocks HIV-1 infection through this dNTP triphosphohydrolase activity...
Autores principales: | Ordonez, Paula, Kunzelmann, Simone, Groom, Harriet C. T., Yap, Melvyn W., Weising, Simon, Meier, Chris, Bishop, Kate N., Taylor, Ian A., Stoye, Jonathan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318888/ https://www.ncbi.nlm.nih.gov/pubmed/28220857 http://dx.doi.org/10.1038/srep42824 |
Ejemplares similares
-
Phospho-dependent Regulation of SAMHD1 Oligomerisation Couples Catalysis and Restriction
por: Arnold, Laurence H., et al.
Publicado: (2015) -
Attenuation of reverse transcriptase facilitates SAMHD1 restriction of HIV-1 in cycling cells
por: Tsai, Ming-Han C., et al.
Publicado: (2023) -
A Continuous Enzyme-Coupled Assay for Triphosphohydrolase Activity of HIV-1 Restriction Factor SAMHD1
por: Arnold, Laurence H., et al.
Publicado: (2014) -
Molecular Determinants for Recognition of Divergent SAMHD1 Proteins by the Lentiviral Accessory Protein Vpx
por: Schwefel, David, et al.
Publicado: (2015) -
SAMHD1 protects cancer cells from various nucleoside-based antimetabolites
por: Herold, Nikolas, et al.
Publicado: (2017)